Literature DB >> 1393624

Some solvents for antiepileptics have proepileptic potencies in the WAG/Rij rat model for absence epilepsy.

B W Peeters1, K S Cheung, J M Vossen, A M Coenen.   

Abstract

Some solvents for antiepileptics were tested, for 4 consecutive days, in a rat model (the WAG/Rij inbred strain) for absence epilepsy. Electroencephalogram registrations and behavioral observations suggested that both Tween-80 and a mixture of saline/ethanol/propylene glycol caused an increase in the number of epileptic phenomena. This increase was not significant and restricted to injection day 1 with Tween-80 but was significantly present during all 4 injection days with the saline/ethanol/propylene glycol mixture. Furthermore, with this latter solvent the increase became larger during consecutive days. Because of the proepileptic potencies and the differential time effects of these solvents, their usage should be seriously questioned.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1393624     DOI: 10.1016/0361-9230(92)90092-c

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  4 in total

1.  Effects of polysorbates and Cremophor EL on vascular responses in rat aorta.

Authors:  H Zengil; U Hodoğlugil; Z Güney
Journal:  Experientia       Date:  1995-11-15

2.  Status Epilepticus due to Intraperitoneal Injection of Vehicle Containing Propylene Glycol in Sprague Dawley Rats.

Authors:  Evon S Ereifej; Seth M Meade; Cara S Smith; Keying Chen; Nanette Kleinman; Jeffrey R Capadona
Journal:  Vet Med Int       Date:  2017-07-12

Review 3.  Establishing Drug Effects on Electrocorticographic Activity in a Genetic Absence Epilepsy Model: Advances and Pitfalls.

Authors:  Gilles van Luijtelaar; Gerard van Oijen
Journal:  Front Pharmacol       Date:  2020-04-14       Impact factor: 5.810

4.  Epileptic seizures and occupational exposure to solvents: a cases series.

Authors:  Najla Mechergui; Imen Youssef; Nejla Ben Charrada; Nadia Ben Ali; Mohamed Fredj; Nizar Ladhari
Journal:  Med Lav       Date:  2019-02-22       Impact factor: 1.275

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.